Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3)

Market Cap	1.47B +11.5%
Revenue (ttm)	1.29B +24.1%
Net Income	241.62M +95.6%
EPS	4.49 +95.6%
Shares Out	53.77M
PE Ratio	6.08
Forward PE	n/a
Dividend	1.29 (4.73%)
Ex-Dividend Date	Apr 17, 2026

Volume	52,800
Open	27.00
Previous Close	27.30
Day's Range	26.95 - 27.20
52-Week Range	20.90 - 34.69
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About BVMF:OFSA3

Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including anti-inflammatories, antibiotics, anticoccidials, antimastitics, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, thera...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,086
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: OFSA3

Financial Performance

In 2025, BVMF:OFSA3's revenue was 1.22 billion, an increase of 19.54% compared to the previous year's 1.02 billion. Earnings were 222.31 million, an increase of 65.50%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 24, 2026

Data Sources Report a data error